NEXGEL Inc (NXGL) - Kewajiban jangka dawa marang modal

Lambang korporat lan logo NEXGEL Inc (NXGL)

NEXGEL, Inc. (NXGL) price action relies on regulatory approvals and pharmacy contracts. The long-term debt-to-equity ratio on the GURU.Markets base chart visualizes financial risks, where the 1.31 mark records this metric. The company's development is based on the release of innovative hydrogel patches, while production is supported by the implementation of eco-friendly polymers and the reduction of the carbon footprint.

NEXGEL, Inc - Utang jangka dawa marang modal NXGL (periode 04.07.2022 - 29.10.2026)
Produk mawa merek NEXGEL, Inc.

This indicator measures the proportion of long-term debt relative to equity, determining the company's degree of financial leverage. Analyzing the long-term debt-to-equity ratio helps identify the balance between bankruptcy risk and the efficiency of borrowed capital utilization. A decrease in this metric often signals an increase in the issuer's fundamental stability. For NEXGEL, Inc. (NXGL), which invests in highly qualified chemical engineers, low leverage ensures the stability of social guarantees for employees. This minimizes the niche production's dependence on credit market volatility.

Perusahaan pesaing

Rasio utang jangka dawa marang ekuitas Intuitive Surgical, Inc. (ISRG)|Utang jangka dawa marang modal DHR|BDX - Kewajiban jangka dawa marang modal|Utang jangka dawa marang modal STE (STERIS plc)|WST: Rasio utang jangka dawa marang modal|Baxter - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal Masimo Corp MASI|STVN: Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Teleflex Corp|MMSI (Merit Medical Systems) - Utang jangka dawa marang modal|Utang jangka dawa marang modal envistaco.com|Utang jangka dawa marang ekuitas ICU Medical (ICUI)|Utang jangka dawa marang ekuitas XRAY (Dentsply Sirona Inc)|LeMaitre - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal ATRC|STAAR Surgical Company - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal ChromaDex Corp NAGE|ZimVie (ZIMV) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal ANGO|Utang jangka dawa marang ekuitas Cerus Corp|Teknova Inc (TKNO) - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas MGRM (Monogram Technologies)|Rasio silihan jangka dawa marang modal STSS|Utang jangka dawa marang ekuitas InfuSystem Holdings, Inc. INFU|Koefisien utang jangka dawa marang modal UTMD|KRMD: Rasio utang jangka dawa marang ekuitas|NYXH - Utang jangka dawa marang modal|Microbot Medical Inc. (MBOT) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas pro-dex.com|ZTEK (Zentek) - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Elutia Inc ELUT|Utang jangka dawa marang ekuitas Milestone Scientific Corp (MLSS)|retractable.com - Rasio utang jangka dawa marang modal|Harvard Bioscience, Inc. - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka dawa marang modal FEMY (femasys.com)|MHUA - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal Predictive Oncology POAI|callanjmb.com (CJMB) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal ATRI|NURO (NeuroMetrix, Inc.) - Utang jangka dawa marang modal